Author | Paul K. Paik, MD | OncLive

Author | Paul K. Paik, MD

Articles

Dr. Paik on Tepotinib in METex14-Mutated NSCLC

June 27, 2019

Video

Paul K. Paik, MD, discussed using tepotinib—a highly selective, ATP-competitive, reversible, potent MET TKI—to treat patients with non–small cell lung cancer with MET exon 14 skipping mutations.

Dr. Paik on the Potential Approval of Lorlatinib for Patients With ALK-Positive NSCLC

May 09, 2018

Video

Paul K. Paik, MD, clinical director of the Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, discusses how the potential approval of lorlatinib may alter the landscape for patients with ALK-positive non–small cell lung cancer (NSCLC).

Dr. Paik on Resistance Mutations in NSCLC

April 18, 2018

Video

Paul K. Paik, MD, clinical director, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, discusses resistance mutations in patients with non–small cell lung cancer (NSCLC).

Dr. Paik Discusses Advances in Squamous Cell Lung Cancer

January 06, 2018

Video

Paul K. Paik, MD, clinical director, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, discusses recent advancements in squamous cell lung cancer.

x